Dehydrogenase/reductase (SDR family) member 8 (DHRS8, SDR16C2) belongs to the short-chain dehydrogenase/reductase (SDR) superfamily, one of the largest enzyme groups. In addition to the well-known members which participate in the metabolism of important eobiotics and xenobiotics, this superfamily contains many poorly characterized proteins. DHRS8 is a member of the Multisubstrate NADP(H)-dependent SDR16C family, which generally contains insufficiently described enzymes. Despite the limited knowledge about DHRS8, preliminary indicators have emerged regarding its significant function in the modulation of steroidal activity, at least in the case of 3α-adiol, lipid metabolism and detoxification. The aim of this study was to describe additional biochemical properties of DHRS8 and to unify knowledge about this enzyme. The DHRS8 was prepared in recombinant form and its membrane topology in the endoplasmic reticulum as an integral protein with cytosolic orientation was demonstrated. The enzyme participates in the NAD(+)-dependent oxidation of steroid hormones as β-estradiol and testosterone in vitro; apparent K m and V max values were 39.86 µM and 0.80 nmol × mg(-1) × min(-1) for β-estradiol and 1207.29 µM and 3.45 nmol × mg(-1) × min(-1) for testosterone. Moreover, synthetic steroids (methyltestosterone and nandrolone) used as anabolics as well as all-trans-retinol were for the first time identified as substrates of DHRS8. This knowledge of its in vitro activity together with a newly described expression pattern at the protein level in tissues involved in steroidogenesis (adrenal gland and testis) and detoxification (liver, lung, kidney and small intestine) could suggest a potential role of DHRS8 in vivo.

Department of Biochemical Sciences Faculty of Pharmacy in Hradec Králové Charles University Prague Heyrovského 1203 500 05 Hradec Králové Czech Republic

Institute of Legal Medicine Faculty of Medicine Charles University and University Hospital in Hradec Králové Sokolská 581 500 05 Hradec Králové Czech Republic

Zobrazit více v PubMed

FEBS J. 2006 Jan;273(2):292-300 PubMed

Bioinformatics. 1998;14(4):378-9 PubMed

FEBS J. 2007 Sep;274(18):4837-47 PubMed

Chem Biol Interact. 2014 Jan 25;207 :52-7 PubMed

Biochem J. 2006 Oct 1;399(1):101-9 PubMed

J Steroid Biochem Mol Biol. 2003 Jul;86(1):79-92 PubMed

J Biol Chem. 2008 Jul 18;283(29):20299-308 PubMed

Eur J Biochem. 2004 Oct;271(20):4141-6 PubMed

Biochemistry. 2001 Oct 23;40(42):12533-40 PubMed

BMC Genomics. 2009 Aug 07;10:365 PubMed

Biochim Biophys Acta. 2014 Feb;1844(2):316-22 PubMed

Steroids. 1997 Jan;62(1):148-58 PubMed

Endocrinology. 2003 May;144(5):2084-91 PubMed

J Biol Chem. 2012 Mar 16;287(12):9061-71 PubMed

Biochem J. 2009 Apr 1;419(1):113-22, 1 p following 122 PubMed

Arch Biochem Biophys. 2001 Feb 1;386(1):1-10 PubMed

Chem Biol Interact. 2015 Jun 5;234:178-87 PubMed

Chem Biol Interact. 2009 Mar 16;178(1-3):182-7 PubMed

Nucleic Acids Res. 2013 Jul;41(Web Server issue):W349-57 PubMed

Chem Biol Interact. 2013 Feb 25;202(1-3):111-5 PubMed

Mol Cell Endocrinol. 2001 Jan 22;171(1-2):111-7 PubMed

Mol Cell Endocrinol. 2011 Jun 6;339(1-2):45-53 PubMed

Mol Cell Endocrinol. 2006 Mar 27;248(1-2):61-71 PubMed

Arch Biochem Biophys. 2008 Nov 15;479(2):121-30 PubMed

Biochemistry. 2003 Jan 28;42(3):776-84 PubMed

Endocr Res. 1998 Aug-Nov;24(3-4):663-7 PubMed

Biochemistry. 2003 Dec 23;42(50):14838-45 PubMed

Mol Cell Endocrinol. 2006 Mar 27;248(1-2):242-5 PubMed

Bioinformatics. 2001 Sep;17(9):849-50 PubMed

Invest Ophthalmol Vis Sci. 2004 Nov;45(11):3857-62 PubMed

Nucleic Acids Res. 2009 Jul;37(Web Server issue):W465-8 PubMed

Methods Enzymol. 2000;316:372-83 PubMed

J Steroid Biochem Mol Biol. 2010 Oct;122(4):164-71 PubMed

Chem Biol Interact. 2009 Mar 16;178(1-3):99-109 PubMed

J Biol Chem. 1998 Aug 21;273(34):21790-9 PubMed